Publications by authors named "Tiffani Hamilton"

Claim this Profile
E
Effectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles.
Sabrina Fabi, Tiffani Hamilton, Brenda LaTowsky, Rebecca Kazin, Keith Marcus

J Drugs Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study Evaluating the Use of Helium Plasma for Dermal Resurfacing.
J David Holcomb, Michael Kelly, Tiffani K Hamilton, Joseph B DeLozier

Lasers Surg Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma.
Howard Sofen, Kenneth G Gross, Leonard H Goldberg, Harry Sharata, Tiffani K Hamilton

J Am Acad Dermatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
Benjamin Bassichis, Gary Blick, Marcus Conant, David Condoluci, Michael Echavez, Tiffani Hamilton

Dermatol Surg· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial.
Stephen Tyring, Natalia Mendoza, Melanie Appell, Adrian Bibby, Richard Foster, Tiffani Hamilton

Int J Dermatol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the use of injectable poly-L-lactic acid in people of color.
Tiffani K Hamilton, Cheryl M Burgess

J Drugs Dermatol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.
Tiffani Hamilton, Alan Menter, Ivor Caro, Peter Compton, Jeffrey Sobell

Drug Saf· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy.
Tiffani K Hamilton

J Drugs Dermatol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.
Alan Menter, Tiffani K Hamilton, Darryl P Toth, Hoi M Leung, Graham Wetherill

Int J Dermatol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing nonsurgical options for facial restoration.
Tiffani K Hamilton

Dermatol Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
Alice B Gottlieb, Tiffani Hamilton, Ivor Caro, Paul Kwon, Peter G Compton

J Am Acad Dermatol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations of efalizumab therapy in patients with psoriasis.
Tiffani K Hamilton

Semin Cutan Med Surg· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
Alan Menter, Kenneth Gordon, Wayne Carey, Tiffani Hamilton, Scott Glazer

Arch Dermatol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.
Kenneth B Gordon, Kim A Papp, Tiffani K Hamilton, Patricia A Walicke, Wolfgang Dummer

JAMA· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.
Mark Lebwohl, Stephen K Tyring, Tiffani K Hamilton, Darryl Toth, Scott Glazer

N Engl J Med· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis